VIDEO: Jaffe discusses GATHER1 trial for geographic atrophy treatment

ByGlenn J. Jaffe, MD

ByDavid W. Mullin

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress here, Glenn J. Jaffe, MD, discusses a post hoc analysis of the GATHER1 trial of geographic atrophy lesion growth.

Published by:

Sources/Disclosures

Collapse

Source:

Jaffe G. Evaluation of GA lesion growth by minimum distance to the fovea center: Post hoc analysis of the GATHER1 trial. Presented at: Retina World Congress; May 12-15, 2022; Fort Lauderdale, Fla.

Disclosures: Jaffe reports no relevant financial disclosures.

Read more about

geographic atrophy

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment